Takeda Pharmaceutical (TAK) Receivables - Other (2018)
Takeda Pharmaceutical (TAK) posted Receivables - Other of $18.6 million for Q1 2018.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Receivables - Other (2018) Analysis & Trends
Takeda Pharmaceutical has reported Receivables - Other for 1 years, with the latest figure at $18.6 million in Q1 2018.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to $18.6 million in Q1 2018; TTM through Mar 2018 was $18.6 million, a N/A change from a year earlier, with the FY2018 full-year figure at $18.6 million, changed N/A from the prior year.
- Receivables - Other was $18.6 million for Q1 2018 at Takeda Pharmaceutical.
- The five-year high for Receivables - Other was $18.6 million in Q1 2018, with the low at $18.6 million in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn |
| 10 | Takeda Pharmaceutical | 2.61 Bn | -3.18 Bn | 5.10 Bn |